Fundz

Acelrx Pharmaceuticals reported raising $10 Million in an initial SEC Form D filing, from an offering of $10 Million

PUBLIC · TLPHJul 28, 2023

Amount Raised

$10 Million

$10 Million sold, per SEC Form D (first sale Jul 17, 2023)

Round Type

Venture

HaywardManufacturingBiotechnologyHealthcareHealth CarePharmaceutical

Quick answer

Talphera, Inc. raised $10 Million in a funding round, dated July 17, 2023. Talphera, Inc. is based in Hayward, California, United States.

How much did Talphera, Inc. raise?
Talphera, Inc. raised $10 Million in a funding round on July 17, 2023.
What does Talphera, Inc. do?
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings.
Where is Talphera, Inc. based and how big is it?
Talphera, Inc. is based in Hayward, California, United States.
Who are the decision-makers at Talphera, Inc?
Fundz holds 1 contact at Talphera, Inc., including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Pharmaceutical around the same time

Companies in the same sectors as Talphera, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Persist AI raised $4M (Seed) on August 4, 2023.
  • Tenon Medical raised $287K (Seed) on July 24, 2023.
  • RedHill Biopharma Ltd raised $2.7M (Seed) on July 21, 2023.
  • CurvaFix raised $39M (Series C) on July 14, 2023.
  • CurvaFix raised $24M on June 29, 2023.
  • Precision Optics Corporation raised $2.5M (Seed) on June 20, 2023.

Who to call at Talphera, Inc., and when

A new round usually means Talphera, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Talphera, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Talphera, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Talphera, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Talphera, Inc.

Location

25821 INDUSTRIAL BOULEVARD

Hayward, California, United States

About

AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. AcelRx’s lead product candidate, Niyad is a lyophilized formulation of nafamostat and is currently being studied under an investigational device exemption, or IDE, as an anticoagulant for the extracorporeal circuit, and has received Breakthrough Device Designation Status from the FDA. AcelRx is also developing two pre-filled syringes in-licensed from its partner Aguettant: Fedsyra™, a pre-filled ephedrine syringe, with an expected NDA filing in the first half of 2023, and PFS-02, a pre-filled phenylephrine syringe with an expected NDA filing in 2024.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Talphera, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsHoward R., Director hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Talphera, Inc.'s next move

See what Strategic adds

Talphera, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.